{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T19:47:55Z","timestamp":1789328875247,"version":"build-2803163510"},"reference-count":156,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.imlet.2017.11.012","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T05:08:37Z","timestamp":1512536917000},"page":"30-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["The IL-1 family of cytokines. Do they have a role in scleroderma fibrosis?"],"prefix":"10.1016","volume":"195","author":[{"given":"Carol M.","family":"Artlett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2017.11.012_bib0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"issue":"2016","key":"10.1016\/j.imlet.2017.11.012_bib0010","first-page":"95","article-title":"Fibrous nests in human hepatocellular carcinoma express a Wnt-induced gene signature associated with poor clinical outcome","volume":"81","author":"Desert","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0015","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00011-016-0977-3","article-title":"Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy","author":"Rubis","year":"2016","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.imlet.2017.11.012_bib0020","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.3892\/or.2016.4986","article-title":"Parathyroid hormone\/parathyroid hormone-related peptide regulate osteosarcoma cell functions: focus on the extracellular matrix","volume":"36","author":"Nikitovic","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.imlet.2017.11.012_bib0025","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2016.04.038","article-title":"Tumor microenvironment: the culprit for ovarian cancer metastasis?","volume":"377","author":"Luo","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.imlet.2017.11.012_bib0030","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/QAI.0000000000000894","article-title":"Risk factors associated with quantitative evidence of lung emphysema and fibrosis in an HIV-Infected cohort","volume":"71","author":"Leader","year":"2016","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.imlet.2017.11.012_bib0035","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/labinvest.2010.73","article-title":"Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype","volume":"90","author":"Mathai","year":"2010","journal-title":"Lab. Invest."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.012_bib0040","first-page":"280","article-title":"Rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis: shared mechanistic and phenotypic traits suggest overlapping disease mechanisms","volume":"67","author":"Paulin","year":"2015","journal-title":"Rev. Invest. Clin."},{"key":"10.1016\/j.imlet.2017.11.012_bib0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.yjmcc.2015.11.005","article-title":"Aging and the cardiac collagen matrix: novel mediators of fibrotic remodelling","volume":"93","author":"Horn","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0050","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000364934","article-title":"Low-grade systemic inflammation connects aging, metabolic syndrome and cardiovascular disease","volume":"40","author":"Guarner","year":"2015","journal-title":"Interdisc. Top. Gerontol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0055","doi-asserted-by":"crossref","first-page":"e0143429","DOI":"10.1371\/journal.pone.0143429","article-title":"The impact of PNPLA3 rs738409 SNP on liver fibrosis progression, portal hypertension and hepatic steatosis in HIV\/HCV coinfection","volume":"10","author":"Scheiner","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.imlet.2017.11.012_bib0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/apt.13405","article-title":"Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE","volume":"43","author":"Doycheva","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.imlet.2017.11.012_bib0065","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/BOR.0000000000000219","article-title":"Systemic sclerosis-associated fibrosis: an accelerated aging phenotype?","volume":"27","author":"Luckhardt","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0070","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00281-015-0508-2","article-title":"Matrix remodeling in systemic sclerosis","volume":"37","author":"Leask","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0075","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1007\/s00467-008-0763-8","article-title":"Diabetes and chronic kidney disease: lessons from the Pima Indians","volume":"23","author":"Lemley","year":"2008","journal-title":"Pediat. Nephrol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0080","first-page":"2","article-title":"The role of proximal tubular cells in interstitial fibrosis: understanding TGF-beta1","volume":"30","author":"Phillips","year":"2007","journal-title":"Chang Gung Med. J."},{"key":"10.1016\/j.imlet.2017.11.012_bib0085","first-page":"247","article-title":"Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury","volume":"17","author":"Phillips","year":"2002","journal-title":"Histol. Histopathol."},{"issue":"Suppl. 1","key":"10.1016\/j.imlet.2017.11.012_bib0090","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1513\/AnnalsATS.201410-448MG","article-title":"Mechanisms of alveolar epithelial injury, repair, and fibrosis","volume":"12","author":"Chambers","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.imlet.2017.11.012_bib0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4236\/abb.2014.51004","article-title":"Aging promotes pro-fibrotic matrix production and increases fibrocyte recruitment during acute lung injury","volume":"5","author":"Sueblinvong","year":"2014","journal-title":"Adv. Biosci. Biotechnol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0100","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1084\/jem.20110551","article-title":"Integrating mechanisms of pulmonary fibrosis","volume":"208","author":"Wynn","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2017.11.012_bib0105","doi-asserted-by":"crossref","first-page":"23ra20","DOI":"10.1126\/scitranslmed.3000488","article-title":"Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome","volume":"2","author":"Loeys","year":"2010","journal-title":"Sci. Trans. Med."},{"key":"10.1016\/j.imlet.2017.11.012_bib0110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.imlet.2017.11.012_bib0115","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1034\/j.1600-0676.2000.020005387.x","article-title":"Morphology of liver repair following cholestatic liver injury: resolution of ductal hyperplasia, matrix deposition and regression of myofibroblasts","volume":"20","author":"Ramm","year":"2000","journal-title":"Liver"},{"key":"10.1016\/j.imlet.2017.11.012_bib0120","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s10875-012-9724-x","article-title":"The lupus-derived anti-double-stranded DNA IgG contributes to myofibroblast-like phenotype in mesangial cells","volume":"32","author":"Zhang","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0125","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.taap.2014.03.024","article-title":"Bleomycin-induced epithelial-mesenchymal transition in sclerotic skin of mice: possible role of oxidative stress in the pathogenesis","author":"Zhou","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11010-014-2030-6","article-title":"Human mesenchymal stem cells express a myofibroblastic phenotype in vitro: comparison to human cardiac myofibroblasts","volume":"392","author":"Ngo","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.imlet.2017.11.012_bib0135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.27035","article-title":"Mesodermal mesenchymal cells give rise to myofibroblasts, but not epithelial cells, in mouse liver injury","volume":"60","author":"Lua","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.imlet.2017.11.012_bib0140","first-page":"L326","article-title":"Hyperoxia induces alveolar epithelial-to-mesenchymal cell transition","volume":"306","author":"Vyas-Read","year":"2014","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0145","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nm.3218","article-title":"Origin and function of myofibroblasts in kidney fibrosis","volume":"19","author":"LeBleu","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2017.11.012_bib0150","first-page":"39","article-title":"Microvascular pericytes in healthy and diseased kidneys","volume":"7","author":"Pan","year":"2014","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"key":"10.1016\/j.imlet.2017.11.012_bib0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.12703\/P5-37","article-title":"Origins of fibrosis: pericytes take centre stage","volume":"5","author":"Greenhalgh","year":"2013","journal-title":"F1000prime Rep."},{"key":"10.1016\/j.imlet.2017.11.012_bib0160","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.2174\/138161212802430396","article-title":"Cellular players in lung fibrosis","volume":"18","author":"Lekkerkerker","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.imlet.2017.11.012_bib0165","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jhep.2011.09.021","article-title":"The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis","volume":"56","author":"Kisseleva","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13075-016-0929-x","article-title":"MicroRNAs in fibrosis: opportunities and challenges","volume":"18","author":"O'Reilly","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.11.012_bib0175","first-page":"56","article-title":"Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar","volume":"146","author":"Desmouliere","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0180","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1165\/rcmb.2014-0468OC","article-title":"Reversal of the transcriptome by prostaglandin E2 during myofibroblast dedifferentiation","volume":"54","author":"Wettlaufer","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0185","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1002\/art.30568","article-title":"The inflammasome activating caspase-1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis","volume":"63","author":"Artlett","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.imlet.2017.11.012_bib0190","first-page":"1075","article-title":"Liver fibrosis: a dynamic and potentially reversible process","volume":"25","author":"Povero","year":"2010","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0195","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12026-014-8544-x","article-title":"NLR proteins and parasitic disease","volume":"59","author":"Clay","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/j.imlet.2017.11.012_bib0200","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6973175","article-title":"High glucose and lipopolysaccharide prime NLRP3 inflammasome via ROS\/TXNIP pathway in mesangial cells","volume":"2016","author":"Feng","year":"2016","journal-title":"J. Diabet. Res."},{"key":"10.1016\/j.imlet.2017.11.012_bib0205","doi-asserted-by":"crossref","first-page":"e29695","DOI":"10.1371\/journal.pone.0029695","article-title":"TLR2\/MyD88\/NF-kappaB pathway, reactive oxygen species, potassium efflux activates NLRP3\/ASC inflammasome during respiratory syncytial virus infection","volume":"7","author":"Segovia","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2017.11.012_bib0210","doi-asserted-by":"crossref","first-page":"12077","DOI":"10.1038\/ncomms12077","article-title":"Neutrophils mediate Salmonella Typhimurium clearance through the GBP4 inflammasome-dependent production of prostaglandins","volume":"7","author":"Tyrkalska","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imlet.2017.11.012_bib0215","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.immuni.2016.05.008","article-title":"Inflammasome-dependent induction of adaptive NK cell memory","volume":"44","author":"van den Boorn","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2017.11.012_bib0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1476-9255-8-9","article-title":"Innate immunity and monocyte-macrophage activation in atherosclerosis","volume":"8","author":"Shalhoub","year":"2011","journal-title":"J. Inflamm."},{"key":"10.1016\/j.imlet.2017.11.012_bib0225","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.4049\/jimmunol.1003597","article-title":"Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4T cells that mediate autoimmunity","volume":"186","author":"Lalor","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0230","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.cub.2007.05.074","article-title":"The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes","volume":"17","author":"Feldmeyer","year":"2007","journal-title":"Curr. Biol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0235","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jaci.2010.12.006","article-title":"Mite allergen is a danger signal for the skin via activation of inflammasome in keratinocytes","volume":"127","author":"Dai","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0240","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00281-015-0518-0","article-title":"Beta-amyloid, microglia, and the inflammasome in Alzheimer's disease","volume":"37","author":"Gold","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0245","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00109-016-1481-5","article-title":"Contribution of redox-dependent activation of endothelial Nlrp3 inflammasomes to hyperglycemia-induced endothelial dysfunction","volume":"94","author":"Chen","year":"2016","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.imlet.2017.11.012_bib0250","doi-asserted-by":"crossref","first-page":"G1248","DOI":"10.1152\/ajpgi.90223.2008","article-title":"Inflammasome-mediated regulation of hepatic stellate cells","volume":"296","author":"Watanabe","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0255","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1128\/AAC.06372-11","article-title":"NLRP3 inflammasome is a target for development of broad-spectrum anti-infective drugs","volume":"56","author":"Thacker","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.imlet.2017.11.012_bib0260","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.1156995","article-title":"Innate immune activation through NALP3 inflammasome sensing of asbestos and silica","volume":"320","author":"Dostert","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.imlet.2017.11.012_bib0265","doi-asserted-by":"crossref","first-page":"9035","DOI":"10.1073\/pnas.0803933105","article-title":"The NALP3 inflammasome is essential for the development of silicosis","volume":"105","author":"Cassel","year":"2008","journal-title":"Proc. Natl. Acad. Sci U. S. A."},{"key":"10.1016\/j.imlet.2017.11.012_bib0270","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0275","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.3892\/or.2016.4569","article-title":"Activation of NLRP3 inflammasome enhances the proliferation and migration of A549 lung cancer cells","volume":"35","author":"Wang","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.imlet.2017.11.012_bib0280","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.yexcr.2016.03.009","article-title":"Inflammasome-independent NLRP3 is required for epithelial-mesenchymal transition in colon cancer cells","volume":"342","author":"Wang","year":"2016","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.imlet.2017.11.012_bib0285","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.4049\/jimmunol.1201959","article-title":"Inflammasome-independent NLRP3 augments TGF-beta signaling in kidney epithelium","volume":"190","author":"Wang","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0290","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/370270a0","article-title":"Structure and mechanism of interleukin-1 beta converting enzyme","volume":"370","author":"Wilson","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2017.11.012_bib0295","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cell.2007.12.040","article-title":"Active caspase-1 is a regulator of unconventional protein secretion","volume":"132","author":"Keller","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2017.11.012_bib0300","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/labinvest.2014.100","article-title":"Oxidative stress mediates the conversion of endothelial cells into myofibroblasts via a TGF-beta1 and TGF-beta2-dependent pathway","volume":"94","author":"Montorfano","year":"2014","journal-title":"Lab. Investig."},{"key":"10.1016\/j.imlet.2017.11.012_bib0305","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00011-013-0667-3","article-title":"OxLDL-induced IL-1 beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflammasome activation","volume":"63","author":"Liu","year":"2014","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.imlet.2017.11.012_bib0310","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.bbamcr.2014.07.009","article-title":"Hyperglycemia and angiotensin II cooperate to enhance collagen I deposition by cardiac fibroblasts through a ROS-STAT3-dependent mechanism","volume":"1843","author":"Fiaschi","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.imlet.2017.11.012_bib0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1998.tb08307.x","article-title":"Interleukin-1 beta interleukin-18, and the interleukin-1 beta converting enzyme","volume":"856","author":"Dinarello","year":"1998","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.imlet.2017.11.012_bib0320","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4049\/jimmunol.153.2.712","article-title":"NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site","volume":"153","author":"Cogswell","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0325","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.4049\/jimmunol.1102048","article-title":"IL-1alpha and IL-1beta recruit different myeloid cells and promote different stages of sterile inflammation","volume":"187","author":"Rider","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0330","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1734-1140(10)70359-5","article-title":"Interleukin-1 (IL-1) in stress-induced activation of limbic-hypothalamic-pituitary adrenal axis","volume":"62","author":"Gadek-Michalska","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.imlet.2017.11.012_bib0335","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.4049\/jimmunol.1402155","article-title":"IL-1 receptor type 2 suppresses collagen-induced arthritis by inhibiting IL-1 signal on macrophages","volume":"194","author":"Shimizu","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0340","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1189\/jlb.0113035","article-title":"Mouse neutrophils express the decoy type 2 interleukin-1 receptor (IL-1R2) constitutively and in acute inflammatory conditions","volume":"94","author":"Martin","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0345","doi-asserted-by":"crossref","first-page":"e0138747","DOI":"10.1371\/journal.pone.0138747","article-title":"Expression of interleukin-1 and interleukin-1 receptors type 1 and type 2 in hodgkin lymphoma","volume":"10","author":"Oelmann","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2017.11.012_bib0350","doi-asserted-by":"crossref","first-page":"20311","DOI":"10.1016\/S0021-9258(18)54924-3","article-title":"Interleukin-1 receptor antagonist binds to the type II interleukin-1 receptor on B cells and neutrophils","volume":"266","author":"Dripps","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2017.11.012_bib0355","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1073\/pnas.92.5.1714","article-title":"Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist","volume":"92","author":"Symons","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2017.11.012_bib0360","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1074-7613(02)00514-9","article-title":"The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action","volume":"18","author":"Smith","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2017.11.012_bib0365","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1172\/JCI12568","article-title":"Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis","volume":"107","author":"Kolb","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2017.11.012_bib0370","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/SHK.0b013e318234f7ff","article-title":"A protective role for inflammasome activation following injury","volume":"37","author":"Osuka","year":"2012","journal-title":"Shock"},{"key":"10.1016\/j.imlet.2017.11.012_bib0375","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.2353\/ajpath.2009.080765","article-title":"Disruption of interleukin-1 signaling improves the quality of wound healing","volume":"174","author":"Thomay","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0380","doi-asserted-by":"crossref","first-page":"36864","DOI":"10.1074\/jbc.M111.276790","article-title":"Interleukin-1beta induces increased transcriptional activation of the transforming growth factor-beta-activating integrin subunit beta8 through altering chromatin architecture","volume":"286","author":"Markovics","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2017.11.012_bib0385","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jbiomech.2004.05.009","article-title":"Stress deprivation simultaneously induces over-expression of interleukin-1beta, tumor necrosis factor-alpha, and transforming growth factor-beta in fibroblasts and mechanical deterioration of the tissue in the patellar tendon","volume":"38","author":"Uchida","year":"2005","journal-title":"J. Biomech."},{"key":"10.1016\/j.imlet.2017.11.012_bib0390","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/art.11020","article-title":"Mediation of interleukin-1beta-induced transforming growth factor beta1 expression by activator protein 4 transcription factor in primary cultures of bovine articular chondrocytes: possible cooperation with activator protein 1","volume":"48","author":"Andriamanalijaona","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.11.012_bib0395","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1465-9921-10-100","article-title":"TGF-beta1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1beta but not abrogated by corticosteroids","volume":"10","author":"Doerner","year":"2009","journal-title":"Respir. Res."},{"key":"10.1016\/j.imlet.2017.11.012_bib0400","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1067\/mlc.2002.128468","article-title":"Interleukin-1beta stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-beta-dependent mechanism","volume":"140","author":"Vesey","year":"2002","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.imlet.2017.11.012_bib0405","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.imbio.2012.05.026","article-title":"IL-1beta and TGFbeta2 synergistically induce endothelial to mesenchymal transition in an NFkappaB-dependent manner","volume":"218","author":"Maleszewska","year":"2013","journal-title":"Immunobiol"},{"key":"10.1016\/j.imlet.2017.11.012_bib0410","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/ki.1995.126","article-title":"Cytokines in human renal interstitial fibrosis. I. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblasts","volume":"47","author":"Lonnemann","year":"1995","journal-title":"Kidney Int."},{"key":"10.1016\/j.imlet.2017.11.012_bib0415","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/ki.1995.127","article-title":"Cytokines in human renal interstitial fibrosis. II. Intrinsic interleukin (IL)-1 synthesis and IL-1-dependent production of IL-6 and IL-8 by cultured kidney fibroblasts","volume":"47","author":"Lonnemann","year":"1995","journal-title":"Kidney Int."},{"key":"10.1016\/j.imlet.2017.11.012_bib0420","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13075-017-1331-z","article-title":"Mir-155 is over expressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis","volume":"19","author":"Artlett","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.11.012_bib0425","doi-asserted-by":"crossref","first-page":"e6718","DOI":"10.1371\/journal.pone.0006718","article-title":"Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions","volume":"4","author":"Pottier","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2017.11.012_bib0430","doi-asserted-by":"crossref","first-page":"L1186","DOI":"10.1152\/ajplung.00170.2004","article-title":"Early response to bleomycin is characterized by different cytokine and cytokine receptors profiles in lung","volume":"287","author":"Cavarra","year":"2004","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0435","first-page":"79","article-title":"The role of cell-associated interleukin-1 in bleomycin-induced pulmonary fibrosis","volume":"43","author":"Asada","year":"1996","journal-title":"Tokushima J. Exp. Med."},{"key":"10.1016\/j.imlet.2017.11.012_bib0440","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1038\/jid.2010.120","article-title":"Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis","volume":"130","author":"Aden","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0445","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bbacli.2013.12.001","article-title":"Cells from the skin of patients with systemic sclerosis secrete chitinase 3-like protein 1","volume":"1","author":"Ho","year":"2014","journal-title":"BBA Clin."},{"key":"10.1016\/j.imlet.2017.11.012_bib0450","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s12325-008-0082-2","article-title":"Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer","volume":"25","author":"Yamac","year":"2008","journal-title":"Adv. Ther."},{"key":"10.1016\/j.imlet.2017.11.012_bib0455","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1797512","article-title":"Glycoprotein YKL-40 levels in plasma are associated with fibrotic changes on HRCT in asbestos-exposed subjects","volume":"2017","author":"Vaananen","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.imlet.2017.11.012_bib0460","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1111\/j.1440-1746.2007.05121.x","article-title":"Serum YKL-40 as a marker of disease activity and stricture formation in patients with Crohn's disease","volume":"23","author":"Erzin","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0465","doi-asserted-by":"crossref","first-page":"35282","DOI":"10.1038\/srep35282","article-title":"Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"6","author":"Kumagai","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imlet.2017.11.012_bib0470","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/MPA.0000000000000751","article-title":"Overexpression of YKL-40 predicts poor prognosis in patients undergoing curative resection of pancreatic cancer","volume":"46","author":"Chen","year":"2017","journal-title":"Pancreas"},{"key":"10.1016\/j.imlet.2017.11.012_bib0475","doi-asserted-by":"crossref","first-page":"36107","DOI":"10.1038\/srep36107","article-title":"Targeting inflammasome\/IL-1 pathways for cancer immunotherapy","volume":"6","author":"Guo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imlet.2017.11.012_bib0480","doi-asserted-by":"crossref","first-page":"e1287247","DOI":"10.1080\/2162402X.2017.1287247","article-title":"The Interleukin (IL)-1R1 pathway is a critical negative regulator of PyMT-mediated mammary tumorigenesis and pulmonary metastasis","volume":"6","author":"Dagenais","year":"2017","journal-title":"Oncoimmunol"},{"key":"10.1016\/j.imlet.2017.11.012_bib0485","first-page":"313","article-title":"Interleukin-1 receptor blockade with anakinra provided cessation of fatigue, reduction in inflammation markers and regression of retroperitoneal fibrosis in a patient with Erdheim-Chester disease\u2014case study and a review of literature","volume":"58","author":"Adam","year":"2012","journal-title":"Vnitr. Lek."},{"key":"10.1016\/j.imlet.2017.11.012_bib0490","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1182\/blood-2010-04-279240","article-title":"Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease","volume":"116","author":"Aouba","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2017.11.012_bib0495","first-page":"3786","article-title":"IL-1R1\/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice","volume":"117","author":"Gasse","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2017.11.012_bib0500","first-page":"39","article-title":"Quantitative evaluation of the IL-1 beta and IL-1 receptor antagonist obtained from BALF macrophages in patients with interstitial lung diseases","volume":"14","author":"Mikuniya","year":"1997","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.imlet.2017.11.012_bib0505","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2249.2011.04468.x","article-title":"Genetic variability in the IL1RN gene and the balance between interleukin (IL)-1 receptor agonist and IL-1beta in idiopathic pulmonary fibrosis","volume":"166","author":"Barlo","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0510","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00251-012-0604-6","article-title":"IL1RN genetic variations and risk of IPF: a meta-analysis and mRNA expression study","volume":"64","author":"Korthagen","year":"2012","journal-title":"Immunogenet"},{"key":"10.1016\/j.imlet.2017.11.012_bib0515","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.semarthrit.2013.09.005","article-title":"Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review","volume":"43","author":"Roubille","year":"2014","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.11.012_bib0520","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.11.012_bib0525","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/ard.2005.048371","article-title":"Safety of extended treatment with anakinra in patients with rheumatoid arthritis","volume":"65","author":"Fleischmann","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.11.012_bib0530","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","article-title":"An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist","volume":"360","author":"Aksentijevich","year":"2009","journal-title":"New Eng. J. Med."},{"key":"10.1016\/j.imlet.2017.11.012_bib0535","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.semarthrit.2006.11.002","article-title":"Peritoneal adhesions and intestinal obstructions in patients with familial Mediterranean fever\u2014are they more frequent?","volume":"36","author":"Berkun","year":"2007","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.11.012_bib0540","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1081\/JDI-120013962","article-title":"Different renal pathologies associated with hypothyroidism","volume":"24","author":"Paydas","year":"2002","journal-title":"Renal Fail."},{"key":"10.1016\/j.imlet.2017.11.012_bib0545","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ki.1995.185","article-title":"Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat","volume":"47","author":"Lan","year":"1995","journal-title":"Kidney Int."},{"key":"10.1016\/j.imlet.2017.11.012_bib0550","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/ki.1993.70","article-title":"Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist","volume":"43","author":"Lan","year":"1993","journal-title":"Kidney Int."},{"key":"10.1016\/j.imlet.2017.11.012_bib0555","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00128.2017","article-title":"Bladder fibrosis during outlet obstruction is triggered through the NLRP3 inflammasome and the production of IL-1beta","author":"Hughes","year":"2017","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0560","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0031-1275398","article-title":"Clinical benefits of intra-articular anakinra for persistent knee effusion","volume":"24","author":"Brown","year":"2011","journal-title":"J. Knee Surg."},{"key":"10.1016\/j.imlet.2017.11.012_bib0565","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3928\/01477447-20101021-09","article-title":"Clinical benefits of intra-articular anakinra for arthrofibrosis","volume":"33","author":"Brown","year":"2010","journal-title":"Orthopedics"},{"key":"10.1016\/j.imlet.2017.11.012_bib0570","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5005\/jp-journals-10017-1008","article-title":"Intra-articular anakinra for the treatment of persistent inflammation and arthrofibrosis following anterior cruciate ligament reconstruction","volume":"1","author":"Magnussen","year":"2011","journal-title":"Duke Orthopedic J."},{"key":"10.1016\/j.imlet.2017.11.012_bib0575","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1073\/pnas.96.11.6261","article-title":"Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3","volume":"96","author":"Coeshott","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2017.11.012_bib0580","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1084\/jem.181.5.1917","article-title":"Granzyme A is an interleukin 1 beta-converting enzyme","volume":"181","author":"Irmler","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2017.11.012_bib0585","first-page":"85","article-title":"The proteolytic activation of interleukin-1 beta","volume":"35","author":"Black","year":"1991","journal-title":"Agents Actions Suppl."},{"key":"10.1016\/j.imlet.2017.11.012_bib0590","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.bbrc.2008.12.161","article-title":"Meprin A and meprin alpha generate biologically functional IL-1beta from pro-IL-1beta","volume":"379","author":"Herzog","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.imlet.2017.11.012_bib0595","doi-asserted-by":"crossref","first-page":"9437","DOI":"10.1016\/S0021-9258(19)76559-4","article-title":"Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor","volume":"263","author":"Black","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2017.11.012_bib0600","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-immunol-032414-112306","article-title":"Inflammasome-independent regulation of IL-1-family cytokines","volume":"33","author":"Netea","year":"2015","journal-title":"Ann. Rev. Immunol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0605","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/BF03402053","article-title":"Lack of interferon-gamma production despite the presence of interleukin-18 during cutaneous wound healing","volume":"6","author":"Kampfer","year":"2000","journal-title":"Mol. Med."},{"key":"10.1016\/j.imlet.2017.11.012_bib0610","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cyto.2010.10.002","article-title":"Effects of interleukin-18 on cardiac fibroblast function and gene expression","volume":"53","author":"Fix","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.imlet.2017.11.012_bib0615","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/0267659108101511","article-title":"The effect of daily administration of IL-18 on cardiac structure and function","volume":"23","author":"Platis","year":"2008","journal-title":"Perfusion"},{"key":"10.1016\/j.imlet.2017.11.012_bib0620","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2119\/2008-00024.Xing","article-title":"Felodipine reduces cardiac expression of IL-18 and perivascular fibrosis in fructose-fed rats","volume":"14","author":"Xing","year":"2008","journal-title":"Mol. Med."},{"key":"10.1016\/j.imlet.2017.11.012_bib0625","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2165\/00003495-198500292-00019","article-title":"Felodipine. A calcium-inhibiting vasodilator in refractory hypertension","volume":"29","author":"Andersson","year":"1985","journal-title":"Drugs"},{"key":"10.1016\/j.imlet.2017.11.012_bib0630","first-page":"19","article-title":"Proinflammatory cytokines (IL-12 and IL-18) in immune rheumatic diseases: relation with disease activity and autoantibodies production","volume":"10","author":"Mosaad","year":"2003","journal-title":"Egypt. J. Immunol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0635","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2249.2004.02642.x","article-title":"Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement","volume":"138","author":"Scala","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0640","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1042\/CS20160183","article-title":"Interleukin-18 deficiency protects against renal interstitial fibrosis in aldosterone\/salt-treated mice","volume":"130","author":"Tanino","year":"2016","journal-title":"Clin. Sci."},{"key":"10.1016\/j.imlet.2017.11.012_bib0645","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1096\/fj.15-271734","article-title":"Excess aldosterone is a critical danger signal for inflammasome activation in the development of renal fibrosis in mice","volume":"29","author":"Kadoya","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.imlet.2017.11.012_bib0650","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jss.2007.01.024","article-title":"The mechanism of how anti-IL-18 prevents concanavalin-A-induced hepatic fibrosis on a mouse model","volume":"142","author":"Zhang","year":"2007","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.imlet.2017.11.012_bib0655","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jcp.21348","article-title":"Interleukin-18 stimulates fibronectin expression in primary human cardiac fibroblasts via PI3K-Akt-dependent NF-kappaB activation","volume":"215","author":"Reddy","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0660","doi-asserted-by":"crossref","first-page":"L280","DOI":"10.1152\/ajplung.00380.2004","article-title":"Protection against bleomycin-induced lung injury by IL-18 in mice","volume":"289","author":"Nakatani-Okuda","year":"2005","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0665","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/sj.gt.3301524","article-title":"Intrasplenic transplantation of IL-18 gene-modified hepatocytes: an effective approach to reverse hepatic fibrosis in schistosomiasis through induction of dominant Th1 response","volume":"8","author":"Zhang","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.imlet.2017.11.012_bib0670","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s10067-011-1686-5","article-title":"Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis","volume":"30","author":"Yanaba","year":"2011","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0675","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1136\/ard.2010.148247","article-title":"Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement","volume":"70","author":"Manetti","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.11.012_bib0680","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/annrheumdis-2012-201553","article-title":"Increased serum IL-33 levels may indicate vascular involvement in systemic sclerosis","volume":"72","author":"Terras","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.11.012_bib0685","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.4049\/jimmunol.0903306","article-title":"IL-33 induces IL-13-dependent cutaneous fibrosis","volume":"184","author":"Rankin","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0690","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1093\/humrep\/det238","article-title":"Profibrotic interleukin-33 is correlated with uterine leiomyoma tumour burden","volume":"28","author":"Santulli","year":"2013","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.imlet.2017.11.012_bib0695","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12890-017-0380-z","article-title":"Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis","volume":"17","author":"Lee","year":"2017","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.imlet.2017.11.012_bib0700","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1111\/j.1582-4934.2009.00801.x","article-title":"Interleukin-33 overexpression is associated with liver fibrosis in mice and humans","volume":"14","author":"Marvie","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.imlet.2017.11.012_bib0705","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2013.07.018","article-title":"Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis","volume":"39","author":"McHedlidze","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2017.11.012_bib0710","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gut.2009.193599","article-title":"Expression of interleukin 1-like cytokine interleukin 33 and its receptor complex (ST2L and IL1RAcP) in human pancreatic myofibroblasts","volume":"59","author":"Nishida","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.imlet.2017.11.012_bib0715","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4049\/jimmunol.1200259","article-title":"Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion","volume":"189","author":"Luzina","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0720","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jaci.2014.05.011","article-title":"IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice","volume":"134","author":"Li","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0725","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI30634","article-title":"IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system","volume":"117","author":"Sanada","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2017.11.012_bib0730","doi-asserted-by":"crossref","first-page":"8205","DOI":"10.1074\/jbc.M111.295055","article-title":"Contradictory functions (activation\/termination) of neutrophil proteinase 3 enzyme (PR3) in interleukin-33 biological activity","volume":"287","author":"Bae","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2017.11.012_bib0735","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jdermsci.2016.10.008","article-title":"Nuclear expression of IL-33 in epidermal keratinocytes promotes wound healing in mice","volume":"85","author":"Oshio","year":"2017","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.imlet.2017.11.012_bib0740","doi-asserted-by":"crossref","first-page":"42594","DOI":"10.1074\/jbc.M111.267922","article-title":"Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36alpha, IL-36beta, and IL-36gamma) or antagonist (IL-36Ra) activity","volume":"286","author":"Towne","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2017.11.012_bib0745","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1073\/pnas.1121534109","article-title":"IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist","volume":"109","author":"van de Veerdonk","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2017.11.012_bib0750","first-page":"32489","article-title":"IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis","author":"Johnston","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0755","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.14389","article-title":"Increased expression of the interleukin-36 cytokines in lesions of hidradenitis suppurativa","author":"Thomi","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0760","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1681\/ASN.2016080840","article-title":"IL-36 signaling facilitates activation of the NLRP3 inflammasome and IL-23\/IL-17 axis in renal inflammation and fibrosis","author":"Chi","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0765","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/MPA.0000000000000765","article-title":"Interleukin-36alpha induces inflammatory mediators from human pancreatic myofibroblasts via a MyD88 dependent pathway","volume":"46","author":"Nishida","year":"2017","journal-title":"Pancreas"},{"key":"10.1016\/j.imlet.2017.11.012_bib0770","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.resinv.2017.06.001","article-title":"Overexpression of IL-38 protein in anticancer drug-induced lung injury and acute exacerbation of idiopathic pulmonary fibrosis","volume":"55","author":"Tominaga","year":"2017","journal-title":"Respir. Invest."},{"key":"10.1016\/j.imlet.2017.11.012_bib0775","first-page":"S1","article-title":"The IL-1 family and inflammatory diseases","volume":"20","author":"Dinarello","year":"2002","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.imlet.2017.11.012_bib0780","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1755-1536-5-18","article-title":"Emerging role of the interleukin (IL)-33\/ST2 axis in gut mucosal wound healing and fibrosis","volume":"5","author":"Lopetuso","year":"2012","journal-title":"Fibrogenesis Tissue Rep."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817302833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817302833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T18:00:28Z","timestamp":1693332028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247817302833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":156,"alternative-id":["S0165247817302833"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2017.11.012","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The IL-1 family of cytokines. Do they have a role in scleroderma fibrosis?","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2017.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}